Faiz Anwer MD
@FaizAnwerMD1
Followers
1K
Following
861
Media
20
Statuses
316
Staff Physician @ClevelandClinic, Hematology-Oncology, Multiple Myeloma, BMT Interests: #MultipleMyeloma #Amyloidosis Opinions are my own.
Joined May 2019
Comprehensive assessment of adverse event profiles associated with bispecific antibodies in multiple myeloma .
0
3
8
Real-World Practice Management of Transplant-Eligible Myeloma
0
5
17
RT @jamecancerdoc: Congratulations to the newly appointed leaders in #cancerresearch @ClevelandClinic @caseccc @AaronGerds @MeganKru….
0
8
0
100% for the cure! 50-Mile Ride this year.In honor of my mother and all patients facing cancer. VeloSano, Latin for “swift cure,” is a global fundraising movement for hope and action. Check out my fundraising page -
give.velosano.org
100% for the cure!
0
0
15
RT @ak_abhi_md: Excited to share our case report, published recently:. AA amyloidosis with multiorgan involvement secondary to familial Med….
casereports.bmj.com
Familial Mediterranean fever (FMF) is an autoinflammatory disorder that can lead to progressive AA amyloidosis if not diagnosed and treated promptly. We present a case of a middle-aged male with...
0
2
0
A rare case of Amyloidosis. AA amyloidosis with multiorgan involvement secondary to familial Mediterranean fever (FMF): dreadful consequences of delayed diagnosis and management.
casereports.bmj.com
Familial Mediterranean fever (FMF) is an autoinflammatory disorder that can lead to progressive AA amyloidosis if not diagnosed and treated promptly. We present a case of a middle-aged male with...
0
3
8
Advances in Supportive Care for Multiple Myeloma-Related Bone Disease—A Review.
mdpi.com
Multiple myeloma (MM) is an incurable plasma cell malignancy characterized by the increased production of monoclonal immunoglobulin. Patients with MM are at high risk of suffering from disease-rela...
1
5
20
FDA approved third BCMA targeting T Cell engager Antibody for 4 prior lines of therapy Myeloma patients
fda.gov
FDA grants accelerated approval to linvoseltamab-gcpt for relapsed or refractory multiple myeloma
0
5
15
RT @Myeloma_Doc: #Myeloma Paper of the Day: Patients w/ >8.7 mos between last exposure to prior BCMA-directed therapy & teclistamab have si….
0
11
0
RT @VJOncology: 🎥@ZunairahShah if @RoswellPark discusses real-world disparities in HER2+ mBC outcomes with ADCs:. Watch here➡️ https://t.co….
vjoncology.com
Zunairah Shah, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, discusses real-world survival outcomes in patients with HER2-positive metastatic breast cancer (mBC) treated with antibody-...
0
4
0
📢 Missed our Residency Match Blueprint webinar?. Good news — on the APPNA-NEO YouTube. 🎥 Watch here:. U.S. or international medical student, this session is full of practical insights .#APPNANEO #ResidencyMatch #MedStudentSuccess #MedicalEducation.
0
0
6
Global access to novel MM therapies remains challenging, barriers and suggested strategies to bridge the gap. Global Access to Multiple Myeloma Therapies | JCO Global Oncology
ascopubs.org
PURPOSEInitial reports indicate that access to contemporary therapies currently used in North America for the treatment of multiple myeloma (MM) varies internationally. No studies have quantitatively...
0
4
16
RT @jamecancerdoc: It is wonderful to be part of one of the cancer hospitals in the world as per @Newsweek https:….
0
11
0
We have trials for Allo-CAR T in clinic, review of AlloSct in MM.
0
3
12
It’s that time again. Perspective and guidance from American and International Medical students.
0
0
12
RT @Bethfaiman: #IMS #IMWG consensus recommendations on the definition of high risk #multiplemyeloma, published Jun 9 2025! .
0
2
0